2023年3月2日,

分享這篇文章提供的新聞Oxipit標誌CARPL標誌CARPL平台用戶會訪問完整的Oxipit AI產品組合:ChestLink,質量和ChestEye。CARPL研究是我們的長期合作夥伴和客戶端部署。與CARPL平台,我們可以提出我們的產品很容易拿到全球醫療的觀眾。”——的首席執行官Oxipit Gediminas Peksys維爾紐斯,立陶宛,3月2日2023 / EINPresswire.com——歐洲放射學大會在維也納Oxipit宣布其診斷的人工智能解決方案將在CARPL平台。CARPL平台用戶會訪問完整的Oxipit AI產品組合:ChestLink健康病人報告自動化、質量-實時質量保證和ChestEye初步報告。此舉進一步構建Oxipit策略來增加公司的產品的全球影響力。研究“CARPL是我們的長期合作夥伴和客戶端部署。未來這是一個精明的組織,迅速拿起最新診斷創新。ChestLink Oxipit質量和ChestEye,是獨一無二的,變革和臨床有效的產品,為醫療機構和患者提供實實在在的臨床價值。與CARPL平台,我們可以提出我們的產品很容易拿到全球醫療的觀眾,“說的首席執行官Oxipit Gediminas Peksys。 CARPL connects AI developers and healthcare providers improving access, affordability and quality of medical care globally. It is an end-to-end technology platform for the testing, distribution and deployment of medical imaging AI in clinical practice. CARPL bridges the gap between healthcare AI application providers and clinicians by being a one-stop solution to access, assess, and adopt AI solutions. “CARPL and Oxipit are long-time friends. Oxipit is the boldest AI company on the planet today. They have many firsts to their credit. Their CE approval for autonomous reporting of normal chest X-rays is a landmark achievement that had forever changed the perception and potential of AI applications in Radiology,” says Dr. Vasanth Venugopal, Chief Medical Officer and Clinical Product Lead at CARPL.ai, “With the formalization of our partnership, strengthened by CARPL's capabilities to deploy AI solutions at scale across institutions and Oxipit's robust set of quality audit and autonomous solutions, we envision a future full of infinite possibilities to revolutionize radiology practice.” Full Oxipit product portfolio will be offered on the CARPL platform, helping medical institutions to increase reporting efficiency, addressing radiologist shortages and improving diagnostic quality. ChestLink is the first autonomous AI application to receive a CE Class IIb certification. The application autonomously reports on chest X-rays featuring no abnormalities without any involvement from a radiologist. By autonomously reporting on healthy patient chest X-rays, ChestLink can automate 15-40% of daily reporting workflow depending on the type of medical institution. Oxipit Quality acts as an AI-powered second-reader for diagnostic quality assurance. By analyzing medical images and corresponding radiologist reports, the application can detect diagnostic mistakes in real-time. If the platform detects an unreported finding, it instantly notifies the radiologist to take another look at the study. Oxipit Quality works with chest and MSK X-rays, MMG images and CT scans. ChestEye is an AI-powered CAR application with support for 75 radiological findings. The application includes preliminary reporting and triage features. ChestEye serves as the first step for diagnostic AI adoption, with clients then being able to move automation or quality assurance depending on their usage scenario. This week Oxipit and CARPL are showcasing their products at the European Congress of Radiology in Vienna. Mantas Miksys